Uterine Papillary Serous Carcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2020-02-05
Clinical Trial Update: Treatment Plan for an Individual Patient With Recurrent Uterine Papillary Serous Carcinoma (UPSC) With PIK3CA Gene Mutation [Phase 2, Phase 3]
Clinical trial update detailing a treatment plan for a recurrent uterine papillary serous carcinoma with a PIK3CA mutation; phases 2 and 3 c…